These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4343629)

  • 21. Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity.
    Feltz P
    Appl Neurophysiol; 1979; 42(1-2):47-50. PubMed ID: 222207
    [No Abstract]   [Full Text] [Related]  

  • 22. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
    Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
    J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for NMDA/D2 receptor-receptor interactions in the rat striatum.
    Micheletti G; Lannes B; Warter JM; Zwiller J
    Adv Neurol; 1993; 60():128-32. PubMed ID: 8380517
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of dopamine on firing patterns on striatal units in adult and 21-day-old rats.
    Ewart WR; Williams TD
    Exp Neurol; 1977 Nov; 57(2):434-9. PubMed ID: 198230
    [No Abstract]   [Full Text] [Related]  

  • 26. Possible dopaminergic pathway from substantia nigra to putamen.
    York DH
    Brain Res; 1970 Jun; 20(2):233-49. PubMed ID: 4396620
    [No Abstract]   [Full Text] [Related]  

  • 27. Turning behavior induced by electrical stimulation of the nigro-neostriatal system of the rat.
    Arbuthnott GW; Ungerstedt U
    Exp Neurol; 1975 Apr; 47(1):162-72. PubMed ID: 164362
    [No Abstract]   [Full Text] [Related]  

  • 28. Amphetamine depresses excitatory synaptic transmission at prefrontal cortical layer V synapses.
    Mair RD; Kauer JA
    Neuropharmacology; 2007 Jan; 52(1):193-9. PubMed ID: 16895728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J; Michelot R; Chéramy A
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract]   [Full Text] [Related]  

  • 30. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra.
    Stanic D; Tripanichkul W; Drago J; Finkelstein DI; Horne MK
    Brain Res; 2004 Oct; 1023(1):83-91. PubMed ID: 15364022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of circling behaviour induced in nigro-striatal lesioned rats after peripheral administration of indole derivatives [proceedings].
    Boissier JR; Dumont C; Oberlander C; Peterfalvi M
    Br J Pharmacol; 1976 Nov; 58(3):452P. PubMed ID: 990630
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
    Michelot R; Leviel V; Giorguieff-Chesselet MF; Chéramy A; Glowinski J
    Life Sci; 1979 Feb; 24(8):715-23. PubMed ID: 86931
    [No Abstract]   [Full Text] [Related]  

  • 34. Presynaptic long-term changes in excitability of the corticostriatal pathway.
    Garcia-Munoz M; Young SJ; Groves PM
    Neuroreport; 1992 Apr; 3(4):357-60. PubMed ID: 1325202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine-induced inhibition of synaptic transmission in the inferior mesenteric ganglion of the dog.
    Lins RL; Willems JL
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):367-8. PubMed ID: 4368597
    [No Abstract]   [Full Text] [Related]  

  • 36. A method for investigating neurotransmission in the basal ganglia using combined stimulation and intracerebral drug injection [proceedings].
    Crossman AR; Lee LA; Slater P
    Br J Pharmacol; 1977 Nov; 61(3):488P. PubMed ID: 201329
    [No Abstract]   [Full Text] [Related]  

  • 37. Disposition and role of newly synthesized amines in central catecholaminergic neurons.
    Glowinski J; Besson MJ; Cheramy A; Thierry AM
    Adv Biochem Psychopharmacol; 1972; 6():93-109. PubMed ID: 4341336
    [No Abstract]   [Full Text] [Related]  

  • 38. Intracranial self-stimulation effects along the route of the nigro-striatal bundle.
    Prado-Alcalá RA; Kent EW; Reid LD
    Brain Res; 1975 Feb; 84(3):531-40. PubMed ID: 1122385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in ingestive behaviour following basal ganglia stimulation in cats.
    Gravante G; Sorbera F; Sabatino M; La Grutta V
    Acta Neurol (Napoli); 1985 Oct; 7(5):381-93. PubMed ID: 4061149
    [No Abstract]   [Full Text] [Related]  

  • 40. Striatal monoamines and reserpine and chlorpromazine rigidity.
    Jurna I
    Pharmacol Ther B; 1976; 2(1):113-28. PubMed ID: 178006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.